Skip to main content
. 2022 Mar 28;34(3):276–286. doi: 10.4103/tcmj.tcmj_318_21

Figure 1.

Figure 1

Structures of representative potential antiviral compounds against severe acute respiratory syndrome coronavirus 2. (a) remdesivir. (b) hydroxychloroquine. (c) molnupiravir. (d) PF-00835231 (R1: hydroxyl group)/PF-07304814 (R1: phosphate). (e) PF-07321332